1 | mechanisms | 17,482 |
2 | pathomechanisms | 54 |
3 | pathophysiologies | 22 |
4 | feasibilities | 8 |
5 | subprocesses | 7 |
6 | guises | 5 |
7 | mechanism/s | 5 |
8 | enunciations | 3 |
9 | mechanisms/pathways | 3 |
10 | nhbs | 3 |
11 | poly-adp-ribosylation | 3 |
12 | cihuateteo | 2 |
13 | cotelydons | 2 |
14 | moralities | 2 |
15 | precipitators | 2 |
16 | reclassifications | 2 |
17 | uripenicillins | 2 |
18 | abnormailities | 1 |
19 | bat1 | 1 |
20 | chain-mechanisms | 1 |
21 | channel/transporters | 1 |
22 | chemicals-endocrine | 1 |
23 | chemo-potentiation | 1 |
24 | choriocapillaries | 1 |
25 | choriomnionitis | 1 |
26 | clockwork | 1 |
27 | cocarcinogenicity | 1 |
28 | component/s | 1 |
29 | creb-regulated | 1 |
30 | decision-making-rules | 1 |
31 | diagnosi | 1 |
32 | fine-tuners | 1 |
33 | ftsz-genes | 1 |
34 | fusion-scission-dilacerations | 1 |
35 | his309 | 1 |
36 | hrtfm2 | 1 |
37 | jc-virus | 1 |
38 | lcrs | 1 |
39 | least-cited | 1 |
40 | loadcases | 1 |
41 | micro-mechanisms | 1 |
42 | molecules/factors | 1 |
43 | non-ppar-gamma | 1 |
44 | norsk | 1 |
45 | oxidoresistance | 1 |
46 | pparγ- | 1 |
47 | prevailingly | 1 |
48 | professional/academic | 1 |
49 | professionnals | 1 |
50 | profiteers | 1 |
51 | ral-gtpase | 1 |
52 | secretagogue-specific | 1 |
53 | stretch-loads | 1 |
54 | terminology/procedures | 1 |
55 | timetree | 1 |
56 | β2aragonist | 1 |
1 | abnormailities | 1 |
2 | bat1 | 1 |
3 | chain-mechanisms | 1 |
4 | channel/transporters | 1 |
5 | chemicals-endocrine | 1 |
6 | chemo-potentiation | 1 |
7 | choriocapillaries | 1 |
8 | choriomnionitis | 1 |
9 | cihuateteo | 2 |
10 | clockwork | 1 |
11 | cocarcinogenicity | 1 |
12 | component/s | 1 |
13 | cotelydons | 2 |
14 | creb-regulated | 1 |
15 | decision-making-rules | 1 |
16 | diagnosi | 1 |
17 | enunciations | 3 |
18 | feasibilities | 8 |
19 | fine-tuners | 1 |
20 | ftsz-genes | 1 |
21 | fusion-scission-dilacerations | 1 |
22 | guises | 5 |
23 | his309 | 1 |
24 | hrtfm2 | 1 |
25 | jc-virus | 1 |
26 | lcrs | 1 |
27 | least-cited | 1 |
28 | loadcases | 1 |
29 | mechanism/s | 5 |
30 | mechanisms | 17,482 |
31 | mechanisms/pathways | 3 |
32 | micro-mechanisms | 1 |
33 | molecules/factors | 1 |
34 | moralities | 2 |
35 | nhbs | 3 |
36 | non-ppar-gamma | 1 |
37 | norsk | 1 |
38 | oxidoresistance | 1 |
39 | pathomechanisms | 54 |
40 | pathophysiologies | 22 |
41 | poly-adp-ribosylation | 3 |
42 | pparγ- | 1 |
43 | precipitators | 2 |
44 | prevailingly | 1 |
45 | professional/academic | 1 |
46 | professionnals | 1 |
47 | profiteers | 1 |
48 | ral-gtpase | 1 |
49 | reclassifications | 2 |
50 | secretagogue-specific | 1 |
51 | stretch-loads | 1 |
52 | subprocesses | 7 |
53 | terminology/procedures | 1 |
54 | timetree | 1 |
55 | uripenicillins | 2 |
56 | β2aragonist | 1 |
1 | pparγ- | 1 |
2 | bat1 | 1 |
3 | hrtfm2 | 1 |
4 | his309 | 1 |
5 | non-ppar-gamma | 1 |
6 | secretagogue-specific | 1 |
7 | professional/academic | 1 |
8 | creb-regulated | 1 |
9 | least-cited | 1 |
10 | oxidoresistance | 1 |
11 | timetree | 1 |
12 | chemicals-endocrine | 1 |
13 | ral-gtpase | 1 |
14 | diagnosi | 1 |
15 | clockwork | 1 |
16 | norsk | 1 |
17 | chemo-potentiation | 1 |
18 | poly-adp-ribosylation | 3 |
19 | cihuateteo | 2 |
20 | mechanism/s | 5 |
21 | component/s | 1 |
22 | nhbs | 3 |
23 | stretch-loads | 1 |
24 | pathophysiologies | 22 |
25 | choriocapillaries | 1 |
26 | moralities | 2 |
27 | abnormailities | 1 |
28 | feasibilities | 8 |
29 | decision-making-rules | 1 |
30 | ftsz-genes | 1 |
31 | terminology/procedures | 1 |
32 | loadcases | 1 |
33 | guises | 5 |
34 | subprocesses | 7 |
35 | choriomnionitis | 1 |
36 | professionnals | 1 |
37 | mechanisms | 17,482 |
38 | chain-mechanisms | 1 |
39 | micro-mechanisms | 1 |
40 | pathomechanisms | 54 |
41 | uripenicillins | 2 |
42 | cotelydons | 2 |
43 | reclassifications | 2 |
44 | enunciations | 3 |
45 | fusion-scission-dilacerations | 1 |
46 | lcrs | 1 |
47 | profiteers | 1 |
48 | fine-tuners | 1 |
49 | channel/transporters | 1 |
50 | precipitators | 2 |
51 | molecules/factors | 1 |
52 | jc-virus | 1 |
53 | mechanisms/pathways | 3 |
54 | β2aragonist | 1 |
55 | prevailingly | 1 |
56 | cocarcinogenicity | 1 |